COVID-19 Coinfection With Mucormycosis in a Diabetic Patient

Cureus. 2021 Jun 22;13(6):e15820. doi: 10.7759/cureus.15820. eCollection 2021 Jun.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a form of β-Coronavirus of the Coronaviridae family, has been causing infection among humans worldwide leading to a pandemic emergency. New strains of SARS-CoV-2 have been evolving unceasingly, presenting with various systemic and oral manifestations. There has been an increase in the incidence of secondary infection in the coronavirus infected individual either due to pre-existing factors or the virus by itself is causing such infection, which is still unclear. As it is already known, immunocompromised and uncontrolled diabetic patients have an increased chance of developing mucormycosis. Herein, we report a case who presented with a swelling in the left cheek, eye, and avascular necrosis intraorally, post COVID-19 infection.

Keywords: coronavirus; covid-19; diabetes mellitus; mucormycosis; opportunistic fungal infection.

Publication types

  • Case Reports